1. Home
  2. SNWV vs ALDX Comparison

SNWV vs ALDX Comparison

Compare SNWV & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNWV
  • ALDX
  • Stock Information
  • Founded
  • SNWV 2004
  • ALDX 2004
  • Country
  • SNWV United States
  • ALDX United States
  • Employees
  • SNWV N/A
  • ALDX N/A
  • Industry
  • SNWV
  • ALDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SNWV
  • ALDX Health Care
  • Exchange
  • SNWV NYSE
  • ALDX Nasdaq
  • Market Cap
  • SNWV 309.9M
  • ALDX 270.7M
  • IPO Year
  • SNWV N/A
  • ALDX 2014
  • Fundamental
  • Price
  • SNWV $36.24
  • ALDX $4.81
  • Analyst Decision
  • SNWV Strong Buy
  • ALDX Strong Buy
  • Analyst Count
  • SNWV 1
  • ALDX 2
  • Target Price
  • SNWV $49.00
  • ALDX $9.50
  • AVG Volume (30 Days)
  • SNWV 57.2K
  • ALDX 1.2M
  • Earning Date
  • SNWV 08-11-2025
  • ALDX 08-12-2025
  • Dividend Yield
  • SNWV N/A
  • ALDX N/A
  • EPS Growth
  • SNWV N/A
  • ALDX N/A
  • EPS
  • SNWV N/A
  • ALDX N/A
  • Revenue
  • SNWV $36,190,000.00
  • ALDX N/A
  • Revenue This Year
  • SNWV N/A
  • ALDX N/A
  • Revenue Next Year
  • SNWV N/A
  • ALDX $29.89
  • P/E Ratio
  • SNWV N/A
  • ALDX N/A
  • Revenue Growth
  • SNWV 61.50
  • ALDX N/A
  • 52 Week Low
  • SNWV $5.21
  • ALDX $1.14
  • 52 Week High
  • SNWV $39.83
  • ALDX $7.20
  • Technical
  • Relative Strength Index (RSI)
  • SNWV N/A
  • ALDX 53.97
  • Support Level
  • SNWV N/A
  • ALDX $5.21
  • Resistance Level
  • SNWV N/A
  • ALDX $5.35
  • Average True Range (ATR)
  • SNWV 0.00
  • ALDX 0.33
  • MACD
  • SNWV 0.00
  • ALDX -0.12
  • Stochastic Oscillator
  • SNWV 0.00
  • ALDX 40.70

About SNWV SANUWAVE HEALTH INC

SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: